[
  {
    "ts": null,
    "headline": "New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration",
    "summary": "MARLBOROUGH, Mass., December 02, 2025--New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test",
    "url": "https://finnhub.io/api/news?id=b7193cd9fbc355e1c9152c7fd9766c934088e3ffd4eca1ff364b6c0f35acea7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764681000,
      "headline": "New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration",
      "id": 137662561,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "MARLBOROUGH, Mass., December 02, 2025--New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test",
      "url": "https://finnhub.io/api/news?id=b7193cd9fbc355e1c9152c7fd9766c934088e3ffd4eca1ff364b6c0f35acea7a"
    }
  }
]